Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Pathophysiol. Nov 15, 2014; 5(4): 405-415
Published online Nov 15, 2014. doi: 10.4291/wjgp.v5.i4.405
Published online Nov 15, 2014. doi: 10.4291/wjgp.v5.i4.405
Contemporary review of drug-induced pancreatitis: A different perspective
Whitney Y Hung, Department of Pharmacy, Yale New Haven Hospital, New Haven, CT 06510, United States
Odaliz Abreu Lanfranco, Department of Medicine, Yale New Haven Hospital, New Haven, CT 06510, United States
Author contributions: Hung WY and Abreu Lanfranco O solely contributed to this paper.
Correspondence to: Whitney Y Hung, PharmD, BCPS (AQ-ID), Department of Pharmacy, Yale New Haven Hospital, 20 York Street, New Haven, CT 06510, United States. whitney.hung@ynhh.org
Telephone: +1-203-7894211 Fax: +1-203-8675511
Received: February 20, 2014
Revised: June 17, 2014
Accepted: July 25, 2014
Published online: November 15, 2014
Processing time: 272 Days and 10.4 Hours
Revised: June 17, 2014
Accepted: July 25, 2014
Published online: November 15, 2014
Processing time: 272 Days and 10.4 Hours
Core Tip
Core tip: The knowledge of drug-induced acute pancreatitis (DIAP) is limited by the availability and the quality of the evidence. Potential publication bias may also impact our knowledge of DIAP. Several causative agent classification systems have been proposed, but they require regular updates. In addition, Infrequent prescribed medications and herbal medications are often omitted from those summarized lists. We review the potential mechanisms of DIAP and provide the perspective of deductive reasoning in order to allow clinicians to identify potential DIAP with limited data.